Annual EBIT
-$12.47 M
-$694.00 K-5.89%
December 31, 2023
Summary
- As of February 12, 2025, NRBO annual earnings before interest & taxes is -$12.47 million, with the most recent change of -$694.00 thousand (-5.89%) on December 31, 2023.
- During the last 3 years, NRBO annual EBIT has risen by +$17.25 million (+58.04%).
- NRBO annual EBIT is now -4587.97% below its all-time high of -$266.00 thousand, reached on December 31, 2014.
Performance
NRBO EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBIT
-$6.26 M
+$3.83 M+37.93%
September 30, 2024
Summary
- As of February 12, 2025, NRBO quarterly earnings before interest & taxes is -$6.26 million, with the most recent change of +$3.83 million (+37.93%) on September 30, 2024.
- Over the past year, NRBO quarterly EBIT has dropped by -$4.01 million (-178.05%).
- NRBO quarterly EBIT is now -255.77% below its all-time high of $4.02 million, reached on December 31, 2018.
Performance
NRBO Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBIT
-$25.48 M
-$2.37 M-10.24%
September 30, 2024
Summary
- As of February 12, 2025, NRBO TTM earnings before interest & taxes is -$25.48 million, with the most recent change of -$2.37 million (-10.24%) on September 30, 2024.
- Over the past year, NRBO TTM EBIT has dropped by -$13.01 million (-104.29%).
- NRBO TTM EBIT is now -1503.21% below its all-time high of -$1.59 million, reached on March 31, 2015.
Performance
NRBO TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
NRBO EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -5.9% | -178.1% | -104.3% |
| 3 y3 years | +58.0% | -80.7% | +15.7% |
| 5 y5 years | +19.5% | -71.7% | -26.3% |
NRBO EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -5.9% | +18.4% | -178.1% | +37.9% | -123.0% | at low |
| 5 y | 5-year | -5.9% | +58.0% | -178.1% | +67.9% | -123.0% | +15.7% |
| alltime | all time | -4588.0% | +62.4% | -255.8% | +67.9% | -1503.2% | +24.6% |
NeuroBo Pharmaceuticals EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$6.26 M(-37.9%) | -$25.48 M(+10.2%) |
| Jun 2024 | - | -$10.08 M(+46.5%) | -$23.11 M(+37.3%) |
| Mar 2024 | - | -$6.88 M(+205.7%) | -$16.83 M(+35.0%) |
| Dec 2023 | -$12.47 M(+5.9%) | -$2.25 M(-42.2%) | -$12.47 M(-2.6%) |
| Sep 2023 | - | -$3.89 M(+2.3%) | -$12.80 M(+6.6%) |
| Jun 2023 | - | -$3.81 M(+51.0%) | -$12.01 M(+5.1%) |
| Mar 2023 | - | -$2.52 M(-2.2%) | -$11.42 M(-3.0%) |
| Dec 2022 | -$11.78 M(-23.0%) | -$2.58 M(-16.9%) | -$11.78 M(-14.4%) |
| Sep 2022 | - | -$3.10 M(-3.6%) | -$13.76 M(-2.5%) |
| Jun 2022 | - | -$3.22 M(+12.0%) | -$14.12 M(-4.8%) |
| Mar 2022 | - | -$2.88 M(-37.0%) | -$14.83 M(-3.0%) |
| Dec 2021 | -$15.28 M(-48.6%) | -$4.56 M(+31.8%) | -$15.28 M(-49.4%) |
| Sep 2021 | - | -$3.46 M(-11.8%) | -$30.23 M(+1.4%) |
| Jun 2021 | - | -$3.93 M(+17.9%) | -$29.83 M(+5.4%) |
| Mar 2021 | - | -$3.33 M(-82.9%) | -$28.30 M(-4.8%) |
| Dec 2020 | -$29.72 M(+47.3%) | -$19.52 M(+537.7%) | -$29.72 M(+32.7%) |
| Sep 2020 | - | -$3.06 M(+27.9%) | -$22.39 M(-2.5%) |
| Jun 2020 | - | -$2.39 M(-49.6%) | -$22.98 M(+2.2%) |
| Mar 2020 | - | -$4.75 M(-61.1%) | -$22.47 M(+11.4%) |
| Dec 2019 | -$20.18 M | -$12.19 M(+234.5%) | -$20.18 M(+408.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2019 | - | -$3.65 M(+93.2%) | -$3.96 M(-36.3%) |
| Jun 2019 | - | -$1.89 M(-23.0%) | -$6.23 M(-42.7%) |
| Mar 2019 | - | -$2.45 M(-161.0%) | -$10.87 M(-29.8%) |
| Dec 2018 | -$15.49 M(-53.2%) | $4.02 M(-168.0%) | -$15.49 M(-40.6%) |
| Sep 2018 | - | -$5.91 M(-9.6%) | -$26.07 M(-9.2%) |
| Jun 2018 | - | -$6.53 M(-7.5%) | -$28.70 M(-12.2%) |
| Mar 2018 | - | -$7.06 M(+7.6%) | -$32.69 M(-1.3%) |
| Dec 2017 | -$33.12 M(+125.4%) | -$6.57 M(-23.1%) | -$33.12 M(-2.0%) |
| Sep 2017 | - | -$8.54 M(-18.8%) | -$33.78 M(+17.9%) |
| Jun 2017 | - | -$10.52 M(+40.1%) | -$28.65 M(+43.4%) |
| Mar 2017 | - | -$7.50 M(+3.8%) | -$19.97 M(+35.9%) |
| Dec 2016 | -$14.70 M(+105.0%) | -$7.23 M(+112.5%) | -$14.70 M(+47.3%) |
| Sep 2016 | - | -$3.40 M(+84.9%) | -$9.98 M(+11.6%) |
| Jun 2016 | - | -$1.84 M(-17.3%) | -$8.94 M(+2.6%) |
| Mar 2016 | - | -$2.23 M(-11.4%) | -$8.71 M(+7.9%) |
| Dec 2015 | -$7.17 M(+2594.7%) | -$2.51 M(+6.1%) | -$8.08 M(+45.1%) |
| Sep 2015 | - | -$2.37 M(+47.0%) | -$5.57 M(+74.0%) |
| Jun 2015 | - | -$1.61 M(+1.3%) | -$3.20 M(+101.3%) |
| Mar 2015 | - | -$1.59 M | -$1.59 M |
| Dec 2014 | -$266.00 K | - | - |
FAQ
- What is NeuroBo Pharmaceuticals annual earnings before interest & taxes?
- What is the all time high annual EBIT for NeuroBo Pharmaceuticals?
- What is NeuroBo Pharmaceuticals annual EBIT year-on-year change?
- What is NeuroBo Pharmaceuticals quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for NeuroBo Pharmaceuticals?
- What is NeuroBo Pharmaceuticals quarterly EBIT year-on-year change?
- What is NeuroBo Pharmaceuticals TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for NeuroBo Pharmaceuticals?
- What is NeuroBo Pharmaceuticals TTM EBIT year-on-year change?
What is NeuroBo Pharmaceuticals annual earnings before interest & taxes?
The current annual EBIT of NRBO is -$12.47 M
What is the all time high annual EBIT for NeuroBo Pharmaceuticals?
NeuroBo Pharmaceuticals all-time high annual earnings before interest & taxes is -$266.00 K
What is NeuroBo Pharmaceuticals annual EBIT year-on-year change?
Over the past year, NRBO annual earnings before interest & taxes has changed by -$694.00 K (-5.89%)
What is NeuroBo Pharmaceuticals quarterly earnings before interest & taxes?
The current quarterly EBIT of NRBO is -$6.26 M
What is the all time high quarterly EBIT for NeuroBo Pharmaceuticals?
NeuroBo Pharmaceuticals all-time high quarterly earnings before interest & taxes is $4.02 M
What is NeuroBo Pharmaceuticals quarterly EBIT year-on-year change?
Over the past year, NRBO quarterly earnings before interest & taxes has changed by -$4.01 M (-178.05%)
What is NeuroBo Pharmaceuticals TTM earnings before interest & taxes?
The current TTM EBIT of NRBO is -$25.48 M
What is the all time high TTM EBIT for NeuroBo Pharmaceuticals?
NeuroBo Pharmaceuticals all-time high TTM earnings before interest & taxes is -$1.59 M
What is NeuroBo Pharmaceuticals TTM EBIT year-on-year change?
Over the past year, NRBO TTM earnings before interest & taxes has changed by -$13.01 M (-104.29%)